Literature DB >> 22766507

Quantitative analysis of WRN exonuclease activity by isotope dilution mass spectrometry.

Aswin Mangerich1, Sebastian Veith, Oliver Popp, Jörg Fahrer, Rita Martello, Vilhelm A Bohr, Alexander Bürkle.   

Abstract

Werner syndrome is a disorder characterized by a premature aging phenotype. The disease is caused by mutations in the WRN gene which encodes a DNA helicase/exonuclease which is involved in multiple aspects of DNA metabolism. Current methods mostly rely on radiometric techniques to assess WRN exonuclease activity. Here we present an alternative, quantitative approach based on non-radioactive isotope dilution mass spectrometry (LC-MS/MS). A oligoduplex substrate mimicking the telomeric sequence was used for method development. Released nucleotides, which correlate with the degree of oligoduplex degradation, were dephosphorylated, purified, and quantified by LC-MS/MS. Heavy-isotope-labeled internal standards were used to account for technical variability. The method was validated in terms of reproducibility, time-course and concentration-dependency of the reaction. As shown in this study, the LC-MS/MS method can assess exonuclease activity of WRN mutants, WRN's substrate and strand specificity, and modulatory effects of WRN interaction partners and posttranslational modifications. Moreover, it can be used to analyze the selectivity and processivity of WRN exonuclease and allows the screening of small molecules for WRN exonuclease inhibitors. Importantly, this approach can easily be adapted to study nucleases other than WRN. This is of general interest, because exonucleases are key players in DNA metabolism and aging mechanisms.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22766507      PMCID: PMC4586252          DOI: 10.1016/j.mad.2012.06.005

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  24 in total

1.  Enzymatic mechanism of the WRN helicase/nuclease.

Authors:  Robert M Brosh; Patricia L Opresko; Vilhelm A Bohr
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 2.  Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases.

Authors:  Brian A Kudlow; Brian K Kennedy; Raymond J Monnat
Journal:  Nat Rev Mol Cell Biol       Date:  2007-05       Impact factor: 94.444

3.  DmWRNexo is a 3'-5' exonuclease: phenotypic and biochemical characterization of mutants of the Drosophila orthologue of human WRN exonuclease.

Authors:  Ivan Boubriak; Penelope A Mason; David J Clancy; Joel Dockray; Robert D C Saunders; Lynne S Cox
Journal:  Biogerontology       Date:  2008-10-28       Impact factor: 4.277

4.  p53 modulates RPA-dependent and RPA-independent WRN helicase activity.

Authors:  Joshua A Sommers; Sudha Sharma; Kevin M Doherty; Parimal Karmakar; Qin Yang; Mark K Kenny; Curtis C Harris; Robert M Brosh
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

5.  Poly(ADP-ribose) polymerase 1 regulates both the exonuclease and helicase activities of the Werner syndrome protein.

Authors:  Cayetano von Kobbe; Jeanine A Harrigan; Valérie Schreiber; Patrick Stiegler; Jason Piotrowski; Lale Dawut; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2004-08-03       Impact factor: 16.971

6.  Werner syndrome protein. II. Characterization of the integral 3' --> 5' DNA exonuclease.

Authors:  A S Kamath-Loeb; J C Shen; L A Loeb; M Fry
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

Review 7.  Rising from the RecQ-age: the role of human RecQ helicases in genome maintenance.

Authors:  Vilhelm A Bohr
Journal:  Trends Biochem Sci       Date:  2008-10-14       Impact factor: 13.807

8.  Biochemical and kinetic characterization of the DNA helicase and exonuclease activities of werner syndrome protein.

Authors:  Saba Choudhary; Joshua A Sommers; Robert M Brosh
Journal:  J Biol Chem       Date:  2004-06-08       Impact factor: 5.157

9.  Length-dependent degradation of single-stranded 3' ends by the Werner syndrome protein (WRN): implications for spatial orientation and coordinated 3' to 5' movement of its ATPase/helicase and exonuclease domains.

Authors:  Amrita Machwe; Liren Xiao; David K Orren
Journal:  BMC Mol Biol       Date:  2006-02-17       Impact factor: 2.946

10.  WRN Exonuclease activity is blocked by specific oxidatively induced base lesions positioned in either DNA strand.

Authors:  Zuzanna Bukowy; Jeanine A Harrigan; Dale A Ramsden; Barbara Tudek; Vilhelm A Bohr; Tinna Stevnsner
Journal:  Nucleic Acids Res       Date:  2008-07-25       Impact factor: 16.971

View more
  3 in total

1.  Quantification of cellular poly(ADP-ribosyl)ation by stable isotope dilution mass spectrometry reveals tissue- and drug-dependent stress response dynamics.

Authors:  Rita Martello; Aswin Mangerich; Sabine Sass; Peter C Dedon; Alexander Bürkle
Journal:  ACS Chem Biol       Date:  2013-05-13       Impact factor: 5.100

2.  Site-specific noncovalent interaction of the biopolymer poly(ADP-ribose) with the Werner syndrome protein regulates protein functions.

Authors:  Oliver Popp; Sebastian Veith; Jörg Fahrer; Vilhelm A Bohr; Alexander Bürkle; Aswin Mangerich
Journal:  ACS Chem Biol       Date:  2012-10-29       Impact factor: 5.100

3.  A fluorescence-based exonuclease assay to characterize DmWRNexo, orthologue of human progeroid WRN exonuclease, and its application to other nucleases.

Authors:  Penelope A Mason; Ivan Boubriak; Lynne S Cox
Journal:  J Vis Exp       Date:  2013-12-23       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.